MAINTENANCE AND OPERATION OF A SYNTHETIC CHEMICAL FACILITY Release Date: July 26, 2001 NOTICE: NOT-HD-01-007 RFP AVAILABLE: NIH-NICHD-01-09 National Institute of Child Health and Human Development (http://www.nichd.nih.gov) The Contraception and Reproductive Health Branch (CRHB) of the National Institute of Child Health and Human Development (NICHD) is recompeting its contract for a Synthetic Chemical Facility (SCF) capable of synthesizing potential antifertility agents on a laboratory scale (1-5 grams), as well as on a relatively larger scale (greater than 1 kg). These agents are obtained for comprehensive contraceptive evaluation under current Good Manufacturing Practices (cGMP), including toxicology studies, primate testing, and preclinical safety studies conducted under separate contracts. The NICHD seeks businesses capable of synthesizing drugs, chemicals, chemical intermediates, steroids, and optically pure and/or resolved unnatural amino acids (greater than 99 percent enantiomeric excess), for further contraceptive development by the Government. The areas of chemical synthesis include: (1) steroids, including orally active estrogens without 17-ethynyl alcohol, long- acting androgens, e.g., testosterone bucyclate and 7alpha, 11beta-dimethyl-19- nortestosterone bucyclate, orally active 7alpha-methyl-19-nortestosterone (MENT) analogs, and antiprogestins, e.g., CDB-2914, 21-substituted analogs (second generation) and derivatives (third generation), (2) steroid haptens linked to bovine serum albumin as well as to histamine conjugates for the development of radioimmunoassay (RIA), (3) radiolabeled compounds for RIA as tracers and for metabolism studies, and (4) heterocyclic compounds, including seconucleosides and hexahydro-indenopyridine diastereomers. The required service is defined as code 325412 under the North American Industry Classification System (NAICS). The Request for Proposals (RFP) will be issued on or about July 20, 2001 and will be available on the NICHD web page (http://www.nichd.nih.gov/oam_cmb). Proposals are due by 4:00 P.M. EDT on September 19, 2001. All responsible sources may submit proposals for consideration. In order to be considered for evaluation, the potential offerors must meet the following mandatory requirements at the time of proposal submission: (1) The contractor must have capabilities for relatively large-scale synthesis (1000 grams). (2) The contractor"s facilities must meet requirements for cGMP set up by the Food and Drug Administration (see 21 CFR Parts 201, 207, 210, 211 and 229), must have a nuclear license to handle radioisotopes, and must have a controlled substance license. This notice does not commit the government to award a contract. Proposals should be submitted to: Ms. Annette Carter Contract Specialist Contracts Management Branch National Institute of Child Health and Human Development 6100 Executive Boulevard, Suite 7A07, MSC 7510 Bethesda, MD 20892-7510 Telephone: 301-496-4611 FAX: 301-402-3676 E-mail: nichdcmb@mail.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||
NIH... Turning Discovery Into Health® |